Due to the coronavirus (COVID-19) pandemia, we want to inform all our clients and colleagues that Papula-Nevinpat continues to serve its clients as before.
We have taken measures to minimize possible effects caused by the coronavirus pandemia on our business, and plans exist to manage risks based on a wide range of scenarios. For example, all our employees are fully equipped for remote work. Therefore, we can confirm that we continue to operate without any disruption to our services.
You can be assured that we are closely following all announcements given by patent offices on any exceptional arrangements made in this crisis situation to ensure that all our clients’ IP rights will stay in force.
Papula-Nevinpat is taking every action to minimize the coronavirus infection risk and encourages each of its employees and colleagues to act in a responsible way. Our top priority is to safeguard the health and well-being of our employees, colleagues and others while also recognizing responsibility to our customers and the IP industry.
We closely monitor the pandemia situation and follow all guidelines issued by the Finnish institute for health and welfare, the Russian and Eurasian health authorities, and international organizations, such as WHO.
For any additional questions, please do not hesitate to contact us through our usual communication channels.
Finnish family-owned Delipap is a strong player in the market for baby and femcare products. Technological innovation and strategic trademark protection underpin the company’s brand strategy as it looks to increase international sales. Read our latest case article.
Annual statistics on Russian, Eurasian and Ukrainian patent applications shed more light on the consequences of Russia’s attack and the outlook the foreign companies currently have on the Russian and Ukrainian market as well as the stability of the intellectual property system in the region. Read more.
Finnish tech-startup Woodly is a rising challenger in the market for bio-based plastics. The company is casting a wide IP-protection net as it takes on the opportunity. Read the story of our customer.
Should you opt in or opt out? How will annuities and infringements be handled? What are the costs involved? We’ve put together a summary to help IP professionals manage the complexities of Europe’s new unitary patent system.
